Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,385,215
-
Share change
-
+527,227
-
Total reported value
-
$2,099,000
-
Price per share
-
$0.39
-
Number of holders
-
9
-
Value change
-
+$204,987
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of NOVUS THERAPEUTICS INC - COM (NVUS) as of Q1 2020
As of 31 Mar 2020,
NOVUS THERAPEUTICS INC - COM (NVUS) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,385,215 shares.
The largest 9 holders included
ORBIMED ADVISORS LLC, 683 Capital Management, LLC, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., Rockefeller Capital Management L.P., GEODE CAPITAL MANAGEMENT, LLC, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.